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 Abstract 14 
In the present work different clays have been characterized according to their mycotoxins 15 
adsorbent ability. Firstly, 27 bentonite clays from different geographical origins were evaluated, at 16 
0.02% w/v, using an in vitro screening method versus five mycotoxins (aflatoxin B1, AFB1; 17 
deoxynivalenol, DON; ochratoxin A, OTA; fumonisin B1, FB1; and, zearalenone, ZEN) by 18 
Enzyme-Linked Immunosorbent Assay (ELISA). Subsequently, 7 bentonite clays (6 of which 19 
were tri-octahedral bentonites) selected from the preliminary test, and 7 commercial adsorbent 20 
products were subjected to an in vitro equilibrium adsorption experiment (at 0.02% w/v) against 21 
six concentrations of AFB1 (0.02-4 mg/L), and OTA (0.05-1 mg/L) by using simulated 22 
gastrointestinal (GI) juices, and successively analysed by HPLC-FD. Equilibrium isotherm 23 
functions were fitted to the data by nonlinear regression analysis. 24 
In vitro adsorption equilibrium experiments showed that AFB1 adsorption                                       25 
was very high with all the adsorbents tested. In particular, the seven pre-selected bentonites 26 
adsorbed most of the AFB1 present at the lower level tested, while only three of these reached 27 
more than 50% of OTA adsorption. Adsorption increased inversely to the toxin concentration and 28 
both Langmuir and Freundlich isotherm models fitted well to the data. Generally, the pre-selected 29 
bentonites (B1-B7) showed better mycotoxin adsorption than commercial products (C1-C7) at all 30 
levels of mycotoxins tested. The 10-fold dose increase of the best tri-octahedral bentonite (B4) 31 
rendered a more effective adsorption of OTA, reaching almost 75% of adsorption (at pH 5). 32 
Keywords: aflatoxin B1, ochratoxin A, animal feed, bentonite, decontamination, adsorption 33 
isotherms 34 
Abbreviations 35 
 36 
Aflatoxin B1 (AFB1), Aflatoxin B2 (AFB2), Aflatoxin G1 (AFG1), Aflatoxin G2  (AFG2), Aflatoxins (AFs), 37 
Deoxynivalenol (DON), Enzyme-Linked Immunosorbent Assay (ELISA), European Union (EU), Fluorescence 38 
Detector (FD), Fumonisins (FBs), Fumonisin B1 (FB1), Gastrointestinal (GI), High Performance Liquid 39 
Chromatography (HPLC), International Agency for Research on Cancer (IARC), Maximum Levels (MLs), 40 
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 Ochratoxin A (OTA), Rapid Alert System for Food and Feed (RASFF), Residual Root Mean Square Error (RMSE), 41 
Zearalenone (ZEN). 42 
 43 
Highlights 44 
- Different bentonites have been in vitro tested as mycotoxin detoxifiers. 45 
- In vitro adsorption experiments showed that AFB1 was the most adsorbed mycotoxin. 46 
- Fusarium mycotoxins showed low levels of adsorption, especially for DON, whose 47 
adsorption was negligible. 48 
- Tri-octahedral bentonites showed higher adsorption than di-octahedral bentonites. 49 
- One of the tri-octahedral bentonites assayed proved to be an in vitro efficient AFB1 and 50 
OTA binder. 51 
 52 
  53 
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 1. Introduction  54 
Animal feed plays an important role in the food chain and has implications regarding the 55 
composition and quality of the livestock products (milk, meat, and eggs) for human consumption. 56 
Cereals, especially maize and wheat, constitute most of the daily diet of animals and are important 57 
ingredients in compound feeds (Pinotti et al., 2016). Fungal contamination of grains is a 58 
worldwide problem, especially because cereals used for livestock feed are often imported and 59 
exported across the world (Zulkifli and Zakaria, 2017). Contamination of cereals by fungi can lead 60 
to mycotoxin production which could occur both, at field or because of unsuitable moisture 61 
content or temperature, during storage. In terms of agricultural and animal production, the most 62 
important relevant mycotoxins found in feed are AFs, especially AFB1, mainly produced by 63 
Aspergillus flavus and Aspergillus parasiticus, and OTA produced by Aspergillus ochraceus and 64 
Penicillium verrucosum, whereas ZEN, DON and FB1 are produced by numerous Fusarium 65 
species (Faucet-Marquis et al., 2014; Marin et al., 2013). 66 
Climate change may affect growth of these toxigenic fungi and hence mycotoxin production, 67 
as variations in environmental conditions, including temperature, relative humidity, and 68 
CO2 levels, affect their development. Interactions between these three factors have shown to 69 
stimulate Aspergillus mycotoxins production (Medina et al., 2014). Lately in Europe, AFs 70 
contamination, previously uncommon, has become increasingly significant as a consequence of 71 
rising average temperatures due to climate change, and is expected to increase further (Medina et 72 
al., 2015; Miraglia et al., 2009).  According to the annual report of the RASFF, mycotoxins were 73 
the main hazard in border rejection notifications in the EU in 2017. AFs were the primary 74 
mycotoxins associated to the notifications, and nuts, nut products and seeds were the most affected 75 
categories. Apart from AFs, OTA, FBs and DON were often reported in cereal-based products 76 
(Juan et al., 2013; RASFF, 2017). Recently, Hassan et al. (2018) detected AFs and OTA in 94 and 77 
44% of mixed cereals, 70 and 40% of maize, 40 and 60% of wheat, respectively, in samples from 78 
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 a Qatar market. Moreover, the co-contamination analysis showed that 44, 40 and 50% of the 79 
mixed cereals, maize and barley samples were concurrently contaminated with AFs and OTA. Co-80 
occurrence of AFB1 and OTA had been also previously reported in a range of commodities, 81 
including cereals and feed (Ibáñez-Vea et al., 2011; Iqbal et al., 2014; Kara et al., 2015).   82 
Due to the evidence of carcinogenic effects in humans of these two toxins, the IARC placed 83 
AFB1 in the most toxic group, i.e. group 1, while OTA was placed in group 2B, as a potential 84 
carcinogen (IARC, 1993). AFB1 and OTA, due to their fast absorption at the GI tract, high 85 
carcinogenicity for animals and humans, and high risk of carry-over to derived animal products 86 
(edible tissues, eggs or milk), have very low limits in the EU Regulations and Recommendations 87 
in animal feed, i.e, in the order of µg/kg. AFB1 is the only mycotoxin with EU- MLs in animal 88 
feed (5-20 μg/kg), while OTA is regulated only by guidance values (50-250 μg/kg) (Commission 89 
Recommendation 2006/576 EC; Directive 2003/100 EC). 90 
Generally, the levels of mycotoxins found in animal feed are low enough to ensure compliance 91 
with the regulated/recommended levels. However, farm animals often show symptoms of chronic 92 
mycotoxicosis, even when the concentrations of individual mycotoxins in feeds do not exceed 93 
legal guidance values (Grenier and Oswald, 2011; Streit et al., 2012; Wielogórska et al., 2016).  94 
In view of this, a new functional group was added in the EU in the category of technological 95 
feed additives defined as ‘substances that can suppress or reduce the absorption, promote the 96 
excretion of mycotoxins or modify their mode of action’ (Commission Regulation 386/2009, EC). 97 
A variety of adsorbents have been tested for their ability to sequester mycotoxins from the GI tract 98 
(Avantaggiato et al., 2003, 2005, 2007; Boudergue et al., 2009; Di Gregorio et al., 2014; Kolosova 99 
and Stroka, 2011; Ramos et al., 1996 a, b; Wielogórska et al., 2016). Bentonites, clay materials 100 
composed largely of smectite, have demonstrated a great efficacy on mycotoxins adsorption, 101 
specifically of AFs (Deng et al., 2010; Jaynes et al., 2007; Kong et al., 2014; Magnoli et al., 2011; 102 
5 
 
 Miazzo et al., 2005; Neeff et al., 2013; Pappas et al., 2014; Phillips et al., 2008; Ramos and 103 
Hernández, 1996; Thieu and Peterssson, 2008; Vekiru et al., 2007), and in lesser manner other 104 
mycotoxins (ZEN, and FBs) by in vitro and in vivo studies (Avantaggiato et al., 2005; Feng et al., 105 
2008; Ramos et al., 1996 b; Wang et al., 2012).  106 
It should be noted that, many studies done regarding mycotoxin adsorption have only 107 
investigated the efficacy in the adsorption of a single mycotoxin, tested at levels exceeding EU 108 
limits or guidelines. As mentioned previously, in real situations this is rarely the case (Pappas et al 109 
2014; Streit et al., 2012). In addition, most of the assays were performed in vitro by using 110 
water/buffer solutions, and by testing adsorbents at doses far above those actually used as feed 111 
additives (Vila-Donat et al., 2018). Among the investigated adsorbents, only a di-octahedral 112 
bentonite (1m558) has been authorized as technological additive for reduction of the 113 
contamination of feed with AFB1 for ruminants, poultry and pigs (EC, 2013). 114 
The present study was designed to, firstly, screen 27 bentonite clays from different 115 
geographical origins for their in vitro ability to bind different mycotoxins (AFB1, ZEN, DON, 116 
OTA and FB1) when tested at 0.02% w/v. Secondly, to calculate the in vitro equilibrium 117 
adsorption percentage and adsorption isotherms (by using simulated GI juices) of 7 bentonites 118 
(selected from the preliminary test, for their adsorbent properties) versus AFB1 and OTA 119 
(including levels below EU limits or guidelines), and compare them to 7 commercial products. 120 
And finally, to test the effect of increasing the dosage of the 2 best resulting bentonites up to 0.2% 121 
w/v. 122 
2. Materials and methods 123 
2.1 Reagent and materials 124 
All chemicals used were of analytical grade. Methanol, acetonitrile and acetic acid (HPLC 125 
grade) were purchased from Scharlab S.L (Barcelona, Spain). Ultrapure water was produced by a 126 
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 Milli-Q® system at 22 µm (Millipore, Bedford, MA, USA). For the initial in vitro screening test, 127 
the test medium was acetate buffer (pH 5). It was prepared by combining 0.1 M acetic acid (148 128 
mL) (Panreac, Barcelona, Spain) and 0.1 M sodium acetate (352 mL) (Sigma Aldrich, Misuri, 129 
EEUU) in 500 mL of water. For the equilibrium adsorption experiments and adsorption isotherms, 130 
simulated gastric and intestinal juices were prepared according to The United States 131 
Pharmacopeia/The National Formulary (USP23/NF18, 1995). Simulated gastric juice was 132 
prepared by adding 2 g of sodium chloride (Fischer Scientific, UK), 3.2 g of pepsin from porcine 133 
gastric mucosa, ≥400 units/mg protein (Sigma Aldrich, Misuri, EEUU) and 7 mL of hydrochloric 134 
acid (37 %) (Panreac, Barcelona, Spain) to 1L of water (pH 1.3). Intestinal juice was prepared by 135 
adding 6.8 g of potassium dihydrogen phosphate (Panreac, Barcelona, Spain), 77 mL of sodium 136 
hydroxide 0.2 M, 1.25 g of pancreatin from porcine pancreas, 8 x USP specifications (Sigma 137 
Aldrich, Misuri, EEUU) and 6.75 g of lactose (Probus, S.A, Badalona, Spain) to 1 L of water (pH 138 
6.8).  139 
2.2 Analytical standards 140 
Five mycotoxin standards were used: DON, FB1, ZEN, AFB1, and OTA, supplied by 141 
Biopure Romer Labs Diagnostic Gmbh (Tulln, Austria). Declared purity of all standards was in 142 
the range of 97.6 to 99.5%. Stock solutions (1000-1250 mg/L) were prepared by dissolving 5 mg 143 
of dried mycotoxin in 4-5 mL of methanol (HPLC grade). These solutions were properly diluted 144 
with buffers/simulated juices to prepare the mycotoxin working solutions for adsorption 145 
experiments. Standard solutions were prepared in the mobile phase for HPLC calibration. Stock 146 
solutions were stored in amber vials at −20 °C and brought to room temperature before use.  147 
2.3 Samples  148 
27 bentonite clays kindly provided by a mining company, selected by their mineralogical 149 
composition (>70% smectite), and that differed by their di- and tri-octahedral structure, were 150 
tested. From the total, 16 samples were tri-octahedral bentonites, whereas the remaining 11 were 151 
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 di-octahedral bentonites (Table 2). The tri-octahedral ones are based on a structure where the 152 
octahedral layers are similar to brucite; in the tri-octahedral sheet silicates each O or OH ion is 153 
surrounded by 3 divalent cations, like Mg+2 or Fe+2. Otherwise, the di-octahedral bentonites are 154 
based on a structure where the octahedral layers are similar to gibbsite, since the di-octahedral 155 
sheet silicates is surrounded by 2 trivalent cations, usually Al+3. All bentonites (n=27) were tested 156 
at 0.02% (w/v) using an in vitro screening study (see section 2.4). 157 
From the determination of adsorption percentages obtained from the screening study, 7 158 
bentonite clays (A2, A8, A9, A12, A15, A18, and A22) were selected to be studied in depth by 159 
means of equilibrium adsorption experiments. Selected bentonites (mostly tri-octahedral 160 
bentonites) were recoded as B1, B2, B3, B3, B4, B5, B6 and B7, respectively, and were studied, 161 
along with 7 adsorbents commercially available: C1, C2, C3, C4, C5, C6, and C7 (Table 1) at 0.02 162 
% (w/v) (see section 2.5). Finally, two tri-octahedral bentonites (B2 and B4) were tested at higher 163 
doses, up to 0.2 % (w/v). 164 
2.4 In vitro adsorption screening tests 165 
27 bentonite clays were in vitro tested at 0.02% (w/v) versus 5 mycotoxins (at a single 166 
concentration) tested separately (AFB1: 4 mg/L: DON: 10 mg/L, ZEN: 5 mg/L, OTA: 1 mg/L, 167 
FB1: 10 mg/L). Due to the low amounts of adsorbent to be used, a suspension of clay was 168 
prepared by weighing 100 mg of each adsorbent into a flask with 10 mL of H2O and mixed on a 169 
magnetic stirrer. While stirring, 80 µL of the suspension were pipetted (to make the clay 170 
concentration 0.02 g/100 mL) into 10 mL screw cap Falcon polypropylene tubes to which 4 mL of 171 
acetate buffer (pH 5) were added next along with a single mycotoxin at the specified 172 
concentration. All tubes were placed into an Orbital Shaker-Incubator (2 h, 37 ºC, 4 g). After 173 
shaking, the adsorbent materials were separated from the buffer by centrifugation (8800 g, at 4 ºC 174 
for 10 min) (Avantaggiato et al., 2004, 2007; Dakovíc et al., 2008). Finally, an aliquot of the 175 
supernatants was pipetted and adapted to the proportion of extraction solvent (different for each 176 
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 kit) for ELISA analysis (Ridascreen®, r-Biopharm AG, Darmstadt, Germany). Experiments were 177 
carried out in triplicate, testing each adsorbent by ELISA. Blanks (also in triplicate) were prepared 178 
by adding 4 mL of buffer along with the mycotoxin and without the addition of adsorbent. The 179 
amount of adsorbed mycotoxin was calculated as the difference between the amount of mycotoxin 180 
in the supernatant of the blank tubes and the amount found in the supernatant of the experimental 181 
tubes. This amount was related then to the quantity present in the supernatant of the blank tubes 182 
and expressed as a percentage. 183 
Adsorption analysis was performed by ELISA in vitro tests using a competitive enzyme 184 
immunoassay (Ridascreen®, r-Biopharm AG, Darmstadt, Germany) following the specific 185 
procedure for the quantitative analysis of each mycotoxin (AFB1, ZEN, DON, OTA and FB1) in 186 
cereals. Lectures were performed using a microtiter plate spectrophotometer (Dasitaly, Rome, 187 
Italy). This screening study was performed to select 7 adsorbents to be tested later by using GI 188 
juices. 189 
Concentration of adsorbents tested (0.02% w/v) and assay medium used (buffer solution 190 
pH 5.0) were as described in the authorisation of the 1m558 additive (EC 1060/2013). In the same 191 
way, for AFB1 a concentration of 4 mg/L was used. However, the two best adsorbents selected 192 
after the adsorption isotherm assay (see 2.5) were also tested at 0.12% and 0.2% w/v (testing 4 193 
mg/L of AFB1, and 0.25 mg/L of OTA, assayed separately). 194 
2.5 Equilibrium adsorption isotherms  195 
14 adsorbents (7 selected from the preliminary test and 7 commercial adsorbents) were 196 
subjected to an in vitro equilibrium adsorption experiment, by testing a fixed amount of adsorbent 197 
(0.02 % w/v) against six increasing concentrations of AFB1 (0.02, 0.1, 0.5, 1, 2 and 4 mg/L) or 198 
OTA (0.05, 0.1, 0.25, 0.5, 0.75 and 1 mg/L), using two simulated physiological GI juices (at pH 199 
1.3, and at pH 6.8) and at a constant temperature (37 ºC). 200 
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 To this purpose, a suspension of clay was prepared by weighing 100 mg of each adsorbent 201 
into a flask with 10 mL of H2O and shaking it on the magnetic stirrer. While stirring, 80 µL of the 202 
suspension were pipetted, to make the clay concentration 0.02% (w/v), into 10 mL screw cap 203 
Falcon polypropylene tubes to which 4 mL of simulated gastric (at pH 1.3) or intestinal juice (at 204 
pH 6.8) were added next along with the appropriate concentrations of AFB1 or OTA (previously 205 
mentioned). 206 
All tubes were placed horizontally in an Orbital Shaker-Incubator (2 h, 37 ºC, 4 g). After 207 
the incubation period, the adsorbent materials were separated by centrifugation (8800 g, 4 ºC, 10 208 
min). The supernatants were transferred to clean vials and analysed for the residual mycotoxin 209 
content by HPLC-FD for AFB1 and OTA, as reported below. Experiments were carried out in 210 
triplicate, testing each adsorbent, for each simulated juice and mycotoxin dose, by HPLC analysis. 211 
Blanks (also in triplicate) were prepared by adding 4 mL of simulated gastric/intestinal juices with 212 
the highest, intermediate or lowest concentration tested of mycotoxins and without the addition of 213 
adsorbent. The amount of adsorbed mycotoxin was calculated as the difference between the 214 
amount of mycotoxin in the supernatant of the blank tubes (selecting blank with the dose closest to 215 
the experimental tubes) and the amount found in the supernatant of the experimental tubes with 216 
adsorbent. This amount was related then to the quantity present in the supernatant of the blank 217 
tubes and expressed as a percentage. 218 
2.6 Data calculation and curve fitting 219 
The amount of adsorbed mycotoxin per unit of mass of adsorbent was calculated using the 220 
following equation (eq. 1):  221 
𝑄𝑒𝑞 = ��𝐶𝑜−𝐶𝑒𝑞�𝑉�𝑚                               Equation 1 222 
where: 223 
- 𝑄𝑒𝑞= quantity of mycotoxin adsorbed per milligram of adsorbent (mg/g) 224 
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 - 𝐶𝑜 = concentration of mycotoxin in the supernatants of the blank tubes, with no adsorbent 225 
added (mg/L) 226 
- 𝐶𝑒𝑞= residual mycotoxin concentration in the supernatant of the experimental tubes with 227 
adsorbent at equilibrium (mg/L) 228 
- 𝑉= volume of solution (L) 229 
- 𝑚 = mass of adsorbent (g) 230 
Adsorption equilibrium is established when the quantity of the mycotoxin being adsorbed 231 
(𝑄𝑒𝑞) is equal to the quantity being desorbed. Then the equilibrium concentration in solution (𝐶𝑒𝑞) 232 
remains constant. The adsorption isotherm is a curve obtained by plotting the amount of adsorbed 233 
mycotoxin (𝑄𝑒𝑞) per unit of mass of adsorbent (mg toxin/g adsorbent) against the equilibrium non-234 
adsorbed mycotoxin concentration (mg/L) (𝐶𝑒𝑞). Several theoretical adsorption models have been 235 
developed to describe the equilibrium relationship between adsorbed and non-adsorbed amounts. 236 
Langmuir and Freundlich models are often reported in the literature to provide the best description 237 
of mycotoxin adsorption.  238 
The Langmuir model (Langmuir, 1916) is valid for monolayer adsorption to a surface with 239 
a finite number of identical sites. The expression of the Langmuir model is given by the following 240 
equation (eq. 2): 241 
𝑄𝑒𝑞 = 𝑄𝑚𝑎𝑥 ∗𝐾𝐿∗𝐶𝑒𝑞(1+�𝐾𝐿∗𝐶𝑒𝑞�)                                 Equation 2 242 
where: 243 
- 𝑄𝑒𝑞 = the amount of mycotoxin adsorbed per unit of mass of adsorbent (mg toxin/g 244 
adsorbent) (mg/g)  245 
- 𝐶𝑒𝑞 = residual mycotoxin concentration at equilibrium or non-adsorbed toxin concentration 246 
(mg/L)  247 
- 𝑄𝑚𝑎𝑥 = maximum mycotoxin uptake corresponding to sites saturation (mg/g) 248 
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 - 𝐾𝐿 = Langmuir constant related to the affinity of the adsorbent (L/mg) 249 
The empirical Freundlich (Freundlich, 1906) equation based on adsorption onto a heterogeneous 250 
surface is given by equation (eq. 3): 251 
𝑄𝑒𝑞 = 𝐾𝐹 ∗ 𝐶𝑒𝑞(1 𝑛� )                   Equation 3 252 
where:  253 
-  𝑄𝑒𝑞= the amount of mycotoxin adsorbed per unit of mass of adsorbent (mg toxin/g 254 
adsorbent) (mg/g)  255 
- 𝐶𝑒𝑞= residual mycotoxin concentration at equilibrium or non-adsorbed toxin concentration 256 
(mg/L)  257 
- 𝐾𝐹 = Freundlich constant related to adsorption capacity of the adsorbent for the mycotoxin 258 
(mg/L) 259 
- n = adsorption intensity 260 
In the present work, Langmuir (L) and Freundlich (F) equations were tested. Both adsorption 261 
isotherms were obtained by plotting the concentration of AFB1/OTA in solution after equilibrium 262 
(𝐶𝑒𝑞) against the amount of AFB1/OTA adsorbed per unit of weight of each adsorbent (𝑄𝑒𝑞). Data 263 
obtained from the equilibrium adsorption experiment were transferred to the statistical program 264 
JMP Pro 13.1.0 and fitted to both isotherm models (L and F). The isotherm parameters were 265 
estimated by non-linear regression. Non-linear regression analysis of isotherm data is an 266 
interesting mathematical approach for describing adsorption isotherms at a constant temperature 267 
and to predict the adsorption behaviour under different operating conditions. It was applied to 268 
assess the goodness of the fits and to calculate the parameters involved in the adsorption 269 
mechanism such as maximum adsorption capacity and adsorption affinity (Tables 5 and 6). 270 
2.7 HPLC analysis 271 
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 AFB1 and OTA were analysed by HPLC-FD. Analyses were performed on an Agilent 272 
Technologies 1260 Infinity HPLC (California, EEUU) equipped with a quaternary pump 273 
(G1311B) and a fluorescence detector (G1321B). Data acquisition and instrument control were 274 
performed by Open Lab Chemstation ODS software (Agilent Technologies). AFB1 275 
chromatographic separation was achieved on a Poroshell 120, EC-C18 2.7 µm, 4.6 x 50 mm 276 
column (Agilent Technologies®), at isocratic conditions water/methanol/acetonitrile (70/20/10) as 277 
mobile phase. Column temperature was at 40 ºC, the flow rate was 1.2 mL/min, and the injection 278 
volume 20 µL. Excitation and emission wavelengths were λex = 365 nm, λem = 440 nm. To 279 
enhance the fluorescent activity of AFB1, a derivatization system (UVETM Photochemical reactor, 280 
LCTech GmbH, Dorfen, Germany) was placed between the analytical column and the 281 
fluorescence detector. 282 
 For OTA, chromatographic separation was achieved on a Kinetex PFP 100 Å 5 µm, 4.6 x 283 
150 mm column (Phenomenex®, California, EEUU), and the column temperature was at 40 ºC, the 284 
flow rate was 1 mL/min using mobile phase of A: acetonitrile, B: methanol, C: acetic acid 0.1% in 285 
gradient mode. The gradient elution program started with an initial elution at 15% A, 0% B, 85% 286 
C for 5 min, which changed to 14% A, 27% B, 59% C until 7 min, and continued 90% A, 0% B, 287 
10% C until 12 min when the elution changed back to the initial 15% A, 0% B, 85% C for re-288 
equilibration of the column. The injection volume was 100 µL. Excitation and emission 289 
wavelengths were λex = 329 nm, λem = 460 nm. 290 
Quantification of mycotoxins was based on the external standard method using calibration 291 
curves fitted by linear regression analysis. Linear regression analyses were conducted at optimized 292 
HPLC conditions. The linearity of the calibration graphs was studied by injecting seven-points of 293 
calibration curves of both mycotoxins (AFB1 and OTA) at concentrations of 31-2000 μg/L and 294 
7.5-625 μg/L for AFB1 and OTA, respectively. Correlation coefficients obtained were ≥0.9997 295 
and ≥0.9998 for AFB1 and OTA, respectively. Regarding the sensitivity, the limits of detection 296 
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 (LOD) of the method for both mycotoxins were assessed. LOD was calculated to be 0.09 μg/L and 297 
5 μg/L for AFB1 and OTA respectively. The repeatability and reproducibility of the method was 298 
assessed by injecting five times standard on the same day (intra-day) and over 5 days (inter-day), 299 
respectively.  300 
2.8 Statistical analysis 301 
Analysis of variance (ANOVA) was used to detect statistical differences among the 302 
adsorbents used, concentrations and juices tested (Statgraphics Plus. Version 5.1).  Differences 303 
were considered to be significant at P<0.05. The method used to discriminate among the means 304 
was Fisher's least significant difference (LSD) procedure. 305 
Fitting of adsorption isotherms and estimation of suitable parameters was carried out using JMP 306 
Pro 13.1.0. 307 
 308 
3. Results  309 
3.1 In vitro adsorption screening tests (ELISA) 310 
In the present study a single concentration method was applied to measure the adsorption 311 
of toxins in a buffer solution (pH 5), where a known amount of mycotoxin reacted with a known 312 
amount of adsorbent. Table 2 shows the results of mycotoxin adsorption of the 27 bentonite clays 313 
assayed. More than half of the samples adsorbed more than 70% of the AFB1 present, and eleven 314 
samples adsorbed ≥90% AFB1. Of the latest, all but one (A18 sample), were tri-octahedral 315 
bentonites (Table 2).  316 
Regarding FB1, eleven samples adsorbed ≥30%, and more than half of the samples 317 
presented an adsorption percentage lower than 1%. Only one sample reached more than 70% of 318 
adsorption (A18), whereas for ZEN and OTA this adsorbent only reached 36% and 20% of 319 
adsorption, respectively. The adsorption of DON was negligible (<13%) at the dose tested in this 320 
assay. Adsorbents which showed good adsorbent and mineralogical properties and were available 321 
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 geographically (A2, A8, A9, A12, A15, A18, and A22) were selected to perform a deeper 322 
subsequent adsorption isotherm experiment by using simulated GI fluids (see section 3.2). 323 
It is noteworthy that the present study also revealed that, among the samples tested, tri-324 
octahedral bentonites (A2, A5, A7-A10, A12, A15, A20-A27) showed higher adsorption 325 
capacities than di-octahedral bentonites (A1, A3, A4, A6, A11, A13, A14, A16-A19), with the 326 
exception of A18 (P<0.05). 327 
3.2 Equilibrium adsorption experiments 328 
Six mycotoxin concentrations (including levels below EU limits or recommendations) 329 
were assayed to measure mycotoxin adsorption in simulated GI juices (at pH 1.3 and at pH 6.8), 330 
where a known amount of mycotoxin reacted with a known amount of adsorbent (0.02% w/v). 331 
Results obtained with the 14 adsorbents assayed showed in general similar AFB1 adsorption 332 
percentages at pH 1.3 and at pH 6.8 (Table 3), being slightly higher in basic than in acid GI juice 333 
(P<0.05).  334 
From results presented in Table 3, it can be seen that AFB1 adsorption was high with all 335 
the adsorbents tested (over 82% at 0.02 mg AFB1/L). Adsorption ranged from 30 to 96.6% at the 336 
higher level of AFB1 tested (4 mg AFB1/L) and from 92.1 to >100% at the lower level tested 337 
(0.02 mg AFB1/L) in intestinal simulated juice. So, adsorption increased inversely to toxin 338 
concentration (P < 0.05). Bentonites B1, B2, B4-B7 showed the highest adsorption percentages in 339 
both simulated GI juices, when compared to the results obtained among the 14 adsorbents at the 340 
higher dose of toxin (4 mg AFB1/L): adsorption varied in the range of 72.8-96.6%, reaching all of 341 
these 100% when lower levels of AFB1 (0.02 mg AFB1/L) were tested. Generally, the pre-342 
selected bentonites (B1-B7) tested showed better AFB1 adsorption percentages than commercial 343 
products assayed (C1-C7). (P<0.05). Only two commercial products (C1 and C4) showed a similar 344 
adsorption than pre-selected bentonites (Table 3). 345 
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 Unlike AFB1, OTA adsorption was significantly affected by pH (P <0.05). In fact, in 346 
acidic conditions (pH 1.3), adsorbents were more effective than in basic conditions (pH 6.8) 347 
(Table 4). Experimental values for OTA adsorption, considering only those obtained with 348 
simulated gastric juice, range from 2.4 to 41.5% at the higher level tested (1 mg OTA/L) and in 349 
the range from 8 to 59.8% at the lower level tested (0.05 OTA mg/L) (Table 4). Regarding OTA 350 
adsorption, it increased as toxin concentration decreased, but it was much less pronounced than in 351 
the case of AFB1 (Table 4). Among the 14 adsorbents tested, B2, B4 and B6 showed the greater 352 
adsorption percentages, adsorbing more than half of the toxin (at the lower OTA level tested). 353 
Again, assayed tri-octahedral bentonites proved to be different than commercial products (P<0.05) 354 
(Table 4). 355 
3.3 Adsorption isotherms                                                     356 
Regarding AFB1 adsorption, the maximum adsorbed amounts (𝑄𝑚𝑎𝑥), derived from 357 
Langmuir isotherms at pH 1.3 and at pH 6.8, are summarized in Table 5. With the exception of the 358 
C5 adsorbent, the adsorbents coded as B were those that generally showed higher Qmax, both at 359 
gastric and intestinal pH (Table 5), the adsorbent B6 being the one that showed higher values at 360 
both tested pH. According to the 𝐾𝐿  constant, which is related to the affinity of the adsorbent, B5 361 
at pH 6.8, showed the greater adsorption affinity for AFB1. Regarding Freundlich equation, and 362 
taking into account the 𝐾𝐹 constant, which is related to adsorption capacity of the adsorbent, the 363 
AFB1 adsorption capacities ranged from 15.2±0.3 to 49.1±1.3 mg/L and from 3.4±0.1 to 26.6±1.3 364 
mg/L for pre-selected bentonites (B1-B7) and commercial products (C1-C7), respectively, at pH 365 
6.8 (Table 5). Generally, the samples of bentonites assayed in this study (B1-B7) showed higher 366 
adsorption capacities than commercial products (C1-C7).  367 
Both adsorption models (Langmuir and Freundlich) provided a good fit to experimental 368 
adsorption data of AFB1. As indicated by the root mean square errors (RMSE), the Freundlich 369 
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 model showed a better fit to the AFB1 adsorption data than the Langmuir isotherm. As it can be 370 
seen on Table 5, RMSE values obtained by Freundlich isotherms were generally slightly lower 371 
than those obtained by Langmuir isotherms. As an example, in Fig. 2, four curves obtained fitting 372 
the Langmuir model to AFB1 adsorption experimental data (adsorbents B2 and B4, pH 1.3 and 373 
6.8) can be seen. 374 
Regarding OTA adsorption isotherms, the maximum adsorption capacity (𝑄𝑚𝑎𝑥) at pH 1.3 375 
by using Langmuir model was 1.6±0.2 mg/g for B4, while at pH 6.8 data did not fit (Table 6). 376 
Generally, experimental data of OTA adsorption fitted better to Freundlich equation than to 377 
Langmuir equation, considering in most cases Langmuir parameters did not converge as can be 378 
observed in Table 6. According to 𝐾𝐹 Freundlich constant, tri- octahedral bentonite B4 showed the 379 
higher adsorption capacity at pH 1.3. Curve obtained after plotting experimental data of OTA 380 
adsorption for adsorbent B4 at pH 1.3 can be seen in Fig. 2. 381 
3.4 Effect of adsorbent dosage 382 
The effect of adsorbent dosage on the mycotoxin adsorption process was studied by 383 
increasing the dosage of bentonites B2 and B4 from 0.02% up to 0.2% (w/v) (Table 7).  384 
In both cases, the adsorption was affected by this ten-fold increase even if it was more 385 
pronounced for OTA than for AFB1. In the case of AFB1, significant differences (P<0.05) were 386 
observed between lower and intermediate or higher adsorbent dosage (Table 7), although in all 387 
cases very high absorptions (>96%) were obtained (Table 7). Regarding OTA, the absorption was 388 
significantly affected (P<0.05) by the adsorbent dosage, and the percentage of toxin adsorbed, 389 
increased with increasing dosages of bentonite. Experimental values for the adsorption of OTA 390 
were in the ranges of 3.2-27.7% for B2, and 15.1-75% for B4 (Table 7).  391 
 392 
4. Discussion  393 
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 In vitro preliminary tests of mycotoxin adsorption is a powerful tool for screening potential 394 
mycotoxin adsorbent agents (Boudergue et al., 2009). In the present study, a screening in vitro test 395 
was performed by testing adsorbent clays (n=27) at a very low dose (0.02 % w/v) versus high 396 
levels of mycotoxins (1-10 mg/L). In fact, the mycotoxin doses tested in the preliminary 397 
experiment were well above the EU-MLs or recommendations for mycotoxins in animal feed, 398 
especially for AFB1 and OTA. Regarding AFB1, the concentration tested (4 mg/L) was 200 times 399 
higher than higher EU-MLs (20 μg/kg), whereas OTA was also tested at a concentration 4 times 400 
higher than the higher EU-guidance level (250 μg/kg). Assayed concentrations of ZEN and DON 401 
were closer to the EU-recommendations, while the concentration of FB1 tested was within the 402 
range recommended, considering the high guideline levels established for this toxin, as FB1 has a 403 
very low absorption in animals (Pierron et al., 2016). Anyhow, this preliminary study revealed that 404 
more than half of the adsorbents showed high adsorbing capacity for AFB1 and lower for FB1, 405 
ZEN and OTA, while little DON adsorption was recorded. Our results are in agreement with other 406 
previous works in which several adsorbent materials, including smectites, activated carbons (AC), 407 
polymers such as cholestyramine and other commercial products were tested, and no adsorbent 408 
materials, with the exception of AC and cholestyramine, showed a relevant ability binding DON 409 
(Avantaggiato et al., 2003, 2005, 2007; Döll et al., 2004; Ramos et al., 1996 a, b; Sabater-Vilar et 410 
al., 2007). Regarding AC, DON adsorption abilities vary widely depending on the type of 411 
carbonaceous substances and activation processes. Moreover, the application of AC in animal feed 412 
could adsorb minerals, vitamins and other nutrients as well, and the effectiveness of AC towards 413 
DON could not be confirmed in vivo (Avantaggiato et al., 2004; Sabater-Vilar et al., 2007). 414 
Regarding cholestyramine, the high cost of this polymer would be a limiting factor for its practical 415 
implementation (Avantaggiato et al., 2005; Ramos et al., 1996 b). 416 
A similar experiment was performed by Pappas et al. (2014) who in vitro tested two 417 
bentonites from Greece (assayed at 1% w/v) versus AFB1 (0.02 ppm), ZEN (2 ppm) and OTA 418 
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 (0.1 ppm) by using buffered water at pH 3. Their results indicated a complete adsorption of 0.02 419 
ppm of AFB1 (≈100%) by both bentonites at 1%, and no desorption was observed, whereas 420 
adsorption of ZEN and OTA were low (less than 5 and 18%, respectively). However, in this study 421 
a higher dosage of bentonite (50 times higher) was used compared to our experiment. As far as we 422 
know, there is no published work in which the efficiency of bentonite clays versus five different 423 
mycotoxins was tested using the dose at which the only EU authorized adsorbent has been tested 424 
(0.02%, w/v) (EC, 2013). 425 
Of the latter, seven adsorbents (mainly tri-octahedral bentonites) were selected to perform 426 
a deeper subsequent adsorption isotherm experiment by simulating GI conditions. Six mycotoxin 427 
concentrations of AFB1 and OTA (including levels below EU limits or recommendations) were 428 
assayed to measure mycotoxin adsorption, where known amounts of mycotoxin reacted with a 429 
known amount of adsorbent (0.02% w/v). For this experiment, reasonable concentrations of 430 
mycotoxins and adsorbents were tested using simulated GI juices (at pH 1.3 and at pH 6.8), to 431 
mimic conditions close to an in vivo digestion. In fact, the acidic pH used in this experiment can 432 
be found in some portions of the proventriculus and gizzard of poultry while basic pH can be 433 
found in the distal two parts of the small intestine (jejunum and ileum) (Pappas et al., 2014). Also 434 
in monogastric animals, pH along the GI tract can vary from 1.2 to 4.5 in stomach, increasing 435 
from 5 to 7.5 in the intestinal lumen (Greco et al., 2019). According to experimental data, similar 436 
AFB1 adsorption percentages at pH 1.3 and at pH 6.8 were obtained, being slightly higher in basic 437 
juice than in acid juice (P<0.05). In fact, AFB1 adsorption by bentonites (B1-B7) at concentration 438 
as low as 0.02% (w/v) was very high (approx. 100%), independently of pH. AFB1 is a non-439 
ionizable molecule, therefore a change of pH should not affect AFB1 adsorption. Similar results 440 
were obtained by Dakovíc et al. (2008) for in vitro adsorption of AFB1 by a bentonite from 441 
Bosnia and by a copper modified montmorillonite. They reported that these adsorbents were able 442 
19 
 
 to bind almost 100% of AFB1 at pH 3, and that the binding ability did not change as the pH 443 
increased from 3 to 9.  444 
On the other hand, OTA adsorption was significantly affected by pH (P<0.05). OTA 445 
consists of a dihydroisocoumarin moiety linked through its carboxyl group by an amide linkage to 446 
L-phenylalanine. The decreased OTA adsorption by adsorbents at basic pH may be induced by the 447 
presence of an anionic form of the toxin, which probably leads to repulsion between OTA 448 
molecules and negative charges that could be found on the adsorption surface. Similar findings 449 
were obtained by Dakovíc et al. (2003), who described that OTA adsorption by a 450 
octadecyldimethyl benzyl ammonium exchanged-clinoptilolite-heulandite tuff was higher at pH 3 451 
than pH 7. Also Santos et al., (2011) evaluated the adsorption of OTA by a humic acid polymer, 452 
and described an increased OTA adsorption capacity at pH 3.0, and a partial desorption of this 453 
mycotoxin at pH 8.4. 454 
It should to be noted that the adsorbents (B1-B7) of this study are composed only by the 455 
mineral fraction (>70% smectite), while the commercial products (C1-C7) assayed contained in 456 
addition to the mineral fraction (di-octahedral bentonites), other components, such as organic 457 
additives, to increase their effectiveness or to extend its spectrum of action versus different 458 
mycotoxins. However, bentonites assayed (B1-B7) turned out to be more efficient (P<0.05).  459 
In order to investigate the mechanism of AFB1/OTA adsorption by different adsorbents, 460 
two adsorption models, Langmuir and Freundilich, often reported in literature, were used to 461 
provide the best description of mycotoxin adsorption at pH 1.3 and at pH 6.8. In general, the 462 
adsorption isotherms describe how adsorbates interact with adsorbents and, therefore, they are 463 
crucial in optimizing the use of adsorbents. The Langmuir equation is valid for monolayer 464 
adsorption onto a surface with a finite number of identical sites. As shown above, Langmuir 465 
equation includes a maximum adsorption capacity (𝑄𝑚𝑎𝑥) parameter in the formula. It represents 466 
the maximum adsorbed amount of mycotoxin to form a complete monolayer on the adsorbent 467 
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 surface, corresponding to sites saturation (mg/g). The Freundlich model provides no information 468 
on the monolayer adsorption capacity. In contrast to the Langmuir model, it is based on adsorption 469 
onto a heterogeneous surface and does not have a finite saturation capacity. The heterogeneity 470 
index in the Freundlich model, n, gives information on the population of the binding sites and the 471 
adsorption intensity, and it is associated with the favourability of the binding process. In order to 472 
evaluate the fit of the isotherm to the experimental data, the optimization procedures require a 473 
statistical goodness-of-fit-measure. In this study the RMSE was employed to determine which 474 
isotherm better fitted to our results and values can be observed in Tables 5 and 6. 475 
The fact that the Freundlich isotherm fits slightly better the experimental AFB1/OTA data 476 
may be due to the heterogeneous distribution of active sites on the adsorbent surface, since the 477 
Freundlich equation assumes that the adsorbent has a multilayer adsorption. Similar results were 478 
obtained by Ramos and Hernández (1996) who studied adsorption of AFB1, AFB2, AFG1, and 479 
AFG2 by montmorillonite, at pH 7, and reported that the Freundlich isotherm fitted the 480 
experimental data better than the Langmuir isotherm. Also, Desheng et al. (2005), found that 481 
AFB1 adsorption on calcium montmorillonite, at pH 2 and pH 8, could be determined by both 482 
isotherm models, Langmuir and Freundlich. Conversely, Dakovíc et al. (2008) determined that 483 
AFB1 adsorption by two tested montmorillonites followed a non-linear (Langmuir) type of 484 
isotherm, at pH 3. Also, Santos et al., (2011) described that Langmuir equation proved to be the 485 
best model to predict monolayer equilibrium sorption of OTA onto the humic acid polymer. 486 
Finally, the effect of dosage on mycotoxin adsorption of B2 and B4 bentonites was studied 487 
to calculate the optimal adsorbent dosage for further experiments. The 10-fold dose increase of 488 
bentonite B4 rendered a much more effective adsorption of OTA, reaching almost 75% adsorption 489 
(P<0.05). This greater adsorption of OTA at this dose, together with a very high adsorption of 490 
AFB1, makes this adsorbent a good candidate for subsequent in vivo tests with farm animals. In 491 
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 fact, the addition of 0.2% of adsorbent to the feeds falls within the amounts usually used by feed 492 
manufacturers for this type of products. 493 
 494 
5.  Conclusions 495 
Application of good agricultural practices is not always sufficient to guarantee feed safety, 496 
since undesirable effects can occur even with very low levels of mycotoxin contamination. 497 
In vitro preliminary tests of mycotoxin adsorption is a powerful tool for screening potential 498 
mycotoxin-adsorbent agents before testing in animals since if no adsorption occurs in vitro, little 499 
or no chance exists to do so in vivo. However, complete in vitro studies to determine the stability 500 
of the complex formed in the GI tract are not frequent in literature. Our preliminary study revealed 501 
a high number of adsorbents (most of them tri-octahedral bentonites) able to adsorb most of the 502 
present AFB1 and, to a lesser extent, FB1, ZEN and OTA. However, an efficient adsorbent for 503 
DON was not obtained.   504 
The present work has determined a tri-octahedral bentonite (B4) as an efficient binder of two 505 
highly toxic toxins (AFB1 and OTA), which are increasingly found co-contaminating animal feed. 506 
Moreover, this bentonite showed better in vitro adsorption properties than most of the commercial 507 
products assayed (P<0.05). Addition of tri-octahedral bentonite at a low dosage (from 0.02 up to 508 
0.2%) to the initial composition of feedstuffs would efficiently prevent the mycotoxicosis 509 
originated by these toxins by inducing the formation of a mycotoxin-bentonite complex which 510 
would impede the GI absorption. In vivo studies with different animal species are needed to study 511 
the possible interferences of the selected bentonites with minerals or essential nutrients absorption. 512 
It should be noted that EU-Regulation does not allow the use of adsorbents when the mycotoxin 513 
contamination of feed exceeds the EU-limits or guidelines.  514 
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Figure legends 692 
Figure 1.  Equilibrium adsorption Langmuir isotherms obtained at 37 ºC in gastric (on the left, at 693 
pH 1.3) and intestinal (on the right, at pH 6.8) simulated juices by testing a fixed amount (0.02%, 694 
w/v) of adsorbent B2 (at the top) and B4 (in the bottom) versus increasing concentrations of AFB1 695 
(0.02-4 mg/L). 696 
Figure 2. Equilibrium adsorption Freundlich isotherm obtained at 37 ºC in gastric (pH 1.3) 697 
simulated juice by testing a fixed amount of adsorbent B4 (0.02% w/v) versus increasing 698 
concentrations of OTA (0.05-1 mg/L). 699 
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 Table 1. Mineralogical composition of commercial products (C1-C7). 738 
Commercial binder Composition 
C1 Bentonite (1m558), Sepiolite (E-562) 
C2 Processed montmorillonite, diatomaceous earth, yeast walls, seaweed 
extracts, sugar cane molasses 
C3 Montmorillonite, interspersed montmorillonite, diatomaceous earth, 
yeast walls, seaweed extracts   
C4 Bentonite (1m558), strains of microorganisms (1m01 y 1m03), 
diatomaceous earth, E551c, seaweed meal 
C5 Bentonite (1m558), calcium carbonate, yeast 
C6 Di-octahedral bentonite  
C7 Activated bentonite  
 739 
  740 
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 Table 2. Mycotoxin adsorption, expressed as adsorption percentage (%), of 27 bentonite clays 741 
tested in vitro at pH 5 (acetate buffer) and 0.02 % (w/v) versus AFB1 (4 mg/L), DON (10 mg/L), 742 
OTA (1 mg/L), FB1 (10 mg/L), and ZEN (5 mg/L), assayed separately. 743 
                                                            744 
      Values are average level of three triplicates. % RSDs in all cases were <10. Means with different superscript 745 
letters are different at P<0.05. 746 
  747 
Adsorbent Type of bentonite Mycotoxin adsorption (%) 
Di-octahedral Tri-octahedral AFB1 DON OTA FB1 ZEN 
A1 X  20.1a 6.1 <1a <1a <1a 
A2  X >95.0g 3.4 <1a 40.7fg <1a 
A3 X  26.5a <1 <1a 7.4abc 13.3d 
A4 X  28.4a 5.4 <1a 2.9abc <1a 
A5  X 69.9d <1 <1a 4.1abc <1a 
A6 X  44.1b 4.9 <1a <1a <1a 
A7  X 74.8de <1 <1a 34.5def <1a 
A8  X 89.2fg 12.6 <1a 30.4de <1a 
A9  X 69.0d <1 <1a 1.6ab <1a 
A10  X 88.9fg <1 <1a 30.4de <1a 
A11 X  53.9bc <1 <1a <1a <1a 
A12  X >95.0g <1 <1a 37.3ef <1a 
A13 X  43.8b <1 <1a <1a <1a 
A14 X  54.3bc 1.7 4.0c <1a <1a 
A15  X 95.4g 2.5 6.9d 44.9ef 11.2c 
A16 X  75.9a 3.8 3.9c <1a <1a 
A17 X  75.7de 2.6 4.4c <1a <1a 
A18 X  100g 3.4 20.3h 71.8h 36.4f 
A19 X  65.1cd 3.9 3.3b <1a <1a 
A20  X 81.8ef 5.7 4.0c 8.2bc <1a 
A21  X 76.5de 2.9 4.1c 9.3c <1a 
A22  X 99.2g 4.1 10.5g 45.8g 16.3e 
A23  X 100g 4.2 9.4f 33.7def 14.1d 
A24  X 45.7b 5.2 <1a <1a <1a 
A25  X 96.1g 5.7 8.2e 35.1def 5.0b 
A26  X 90.6g 4.7 5.1e 4.9abc <1a 
A27  X 97.5g 5.1 5.8a 34.2def 2.9a 
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 Table 3. AFB1 adsorption percentages of 14 adsorbents tested at 0.02% (w/v) versus six AFB1 748 
concentrations in gastric (pH 1.3) and intestinal (pH 6.8) simulated juice. B: pre-selected 749 
bentonites; C: commercial adsorbents. 750 
 AFB1 adsorption (%) 
 mg AFB1/L 
Adsorbent Juice 0.02 0.10 0.5 1 2 4 
B1 Gastric >97.5e 98.1e 95.8d 94.2c 91.5b 85.9a 
 Intestinal >99.3c 99.6c 99.4c 98.7c 96.9b 95.0a 
B2 Gastric >99.1e 98.1e 94.5d 92.2c 89.4b 84.9a 
 Intestinal >99.7d 98.5d 98.1d 96.0c 92.8b 89.9a 
B3 Gastric 98.3e 96.3e 86.1d 79.1c 74.7b 62.0a 
 Intestinal 99.6f 98.5e 94.3d 93.0c 82.8b 74.5a 
B4 Gastric >98.0e 98.9e 94.7d 92.4c 89.9b 82.6a 
 Intestinal >99.4c 99.1c 97.8c 95.5b 95.0b 90.7a 
B5 Gastric >97.7c 96.7c 95.3c 91.8b 86.6a 85.1a 
 Intestinal >98.7c 99.4c 99.4c 99.1c 97.9b 96.6a 
B6 Gastric >96.5d 96.4cd 93.4cd 89.3bc 84.5b 79.5a 
 Intestinal >99.3c 98.6c 98.2bc 97.6bc 96.6ab 94.9a 
B7 Gastric >99.1d 97.9cd 97.2cd 89.5bc 82.2b 72.8a 
 Intestinal >99.3d 98.4cd 97.9c 97.7c 95.7b 94.1a 
C1 Gastric >98.7d 92.0c 91.5c 91.3c 82.8b 73.4a 
 Intestinal >99.9d 99.8d 99.4cd 98.4c 95.5b 90.1a 
C2 Gastric 96.8e 77.8d 57.6c 39.1b 38.2b 27.9a 
 Intestinal 92.1f 80.1e 60.3d 42.1c 37.2b 32.5a 
C3 Gastric 82.0f 71.9e 62.1d 49.9c 35.2b 26.4a 
 Intestinal 96.5f 80.1e 72.0d 55.5c 43.4b 30.0a 
C4 Gastric >98.3e 91.6cd 85.7c 74.0b 75.8b 65.6a 
 Intestinal >99.8e >99.8e 99.2d 98.2c 97.6b 90.7a 
C5 Gastric 95.6d 94.3d 87.8cd 81.9bc 75.2b 65.5a 
 Intestinal 97.8d 96.9d 96.2cd 94.4bc 93.3b 88.3a 
C6 Gastric 86.3c 77.8bc 70.5ab 64.0a 63.9a 57.3a 
 Intestinal 98.8d 98.8d 96.4d 90.3c 81.7b 72.9a 
C7 Gastric 92.2c 87.9c 83.3c 71.9b 63.7ab 55.7a 
 Intestinal 98.4d 97.8d 94.0cd 90.2bc 88.3b 74.6a 
Values are average level of three triplicates. % RSDs in all cases were <10. Means with different 751 
superscript letters are different at P<0.05. 752 
 753 
  754 
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 Table 4. OTA adsorption percentages of 14 adsorbents tested at 0.02% (w/v) versus six OTA 755 
concentrations in gastric (pH 1.3) and intestinal (pH 6.8) simulated juice. B: pre-selected 756 
bentonites; C: commercial adsorbents. 757 
 OTA adsorption (%) 
 mg OTA/L  
Adsorbent Juice  0.05 0.10 0.25 0.50 0.75 1 
B1 Gastric 26.3f 18.7b 17.3a 21.8d 21.2c 22.7e 
 Intestinal 6.10f 2.6e 1.3a 1.8c 1.6b 2.0d 
B2 Gastric 59.8f 22.2e 12.5d 8.7c 8.3b 7.9a 
 Intestinal 22.8e 9.7d 3.4c 1.5b <1a <1a 
B3 Gastric 23.6f 8.9e 6.2d 4.1c 2.9b 2.4a 
 Intestinal 7.8d 4.0c 2.6b <1a <1a <1a 
B4 Gastric 50.2f 37.7e 27.4d 23.7c 21.8b 18.4a 
 Intestinal 18.0e 6.7d 3.5a 3.4a 3.9b 4.4c 
B5 Gastric 25.0e 20.5c 20.2b 21.9d 19.5a 20.1b 
 Intestinal 4.7c 1.9b <1a <1a <1a <1a 
B6 Gastric 51.2f 48.6e 44.9d 42.8c 40.4a 41.5b 
 Intestinal 19.8e 12.3d 9.7c 4.9b 3.8a 3.8a 
B7 Gastric 32.1f 31.6e 26.5d 23.8b 23.1a 26.3c 
 Intestinal 14.2e 8.4d 5.3c 3.0a 3.2a 4.2b 
C1 Gastric 37.3e 16.9d 10.8c 7.5b 6.3a 6.2a 
 Intestinal 8.7c 3.5b <1a <1a <1a <1a 
C2 Gastric 14.4f 7.2e 3.6d 3.3c 3.2b 2.5a 
 Intestinal 5.2d 3.3c 1.2b <1a <1a <1a 
C3 Gastric 22.8e 12.5d 7.2c 6.0b 5.9b 5.1a 
 Intestinal 11.8e 5.9d 2.8 c 1.5b 1.2a <1a 
C4 Gastric 27.8e 16.3d 10.7c 5.0a 6.0b 5.0a 
 Intestinal 12.7f 4.6e 2.3d 1.3c 1.1b 0.9a 
C5 Gastric 38.3f 33.2e 27.4d 23.7b 22.5a 24.2c 
 Intestinal 18.0f 11.5e 8.0d 5.4c 4.0a 5.2b 
C6 Gastric 8.0f 2.1d 1.3a 1.6c 1.5b 4.5e 
 Intestinal 8.2d 4.4c 2.3b <1a <1a <1a 
C7 Gastric 17.6e 9.6d 7.1c 4.7a 4.8a 6.2b 
 Intestinal 10.3d 5.9c 2.1a 2.1a 2.1a 3.1b 
Values are average level of three triplicates. % RSDs in all cases were <10. Means with different 758 
superscript letters are different at P<0.05. 759 
 760 
  761 
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 Table 5. AFB1 adsorption (0.02-4 mg/L) Langmuir and Freundlich parameters of 14 adsorbents 762 
tested at 0.02% (w/v), in gastric (pH 1.3) and intestinal (pH 6.8) simulated juice. B: pre-selected 763 
bentonites; C: commercial adsorbents. 764 
                                         Langmuir                                             Freundlich 765 
Adsorbent Juice 𝑸𝒎𝒂𝒙 
(mg/g) 
𝑲𝑳 
(L/mg) 
RMSE 𝑲𝑭 
(mg/L) 
N RMSE 
B1 Gastric 5.2± 0.3 17.5± 2.4 0.09 12.1± 0.6 1.7± 0.1 0.06 
 Intestinal 20.4± 3.4 14.8± 5.9 0.97 38.4± 2.1 1.9± 0.1 0.30 
B2 Gastric 10.2± 0.9 6.4± 1.1 0.16 15.8± 0.1 1.6± 0.0 0.02 
 Intestinal 31.1± 5.8 3.5± 1.3 1.09 31.3± 1.1 1.7± 0.1 0.39 
B3 Gastric 6.7± 0.4 3.8± 0.5 0.13 6.3± 0.2 1.8± 0.1 0.12 
 Intestinal 20.4± 2.9 2.9± 1.1 1.22 15.2± 0.3 2.1± 0.1 0.44 
B4 Gastric 5.2± 0.2 14.1± 1.6 0.08 10.3± 0.6 1.8± 0.1 0.08 
 Intestinal 22.7± 1.7 6.4± 1.0 0.47 29.9± 1.8 1.7± 0.1 0.46 
B5 Gastric 9.0± 3.3 5.2±3.0 0.21 15.2± 1.9 1.4± 0.1 0.13 
 Intestinal 10.6± 1.5 42.6± 15.1 0.45 36.9± 3.4 1.8± 0.1 0.19 
B6 Gastric 13.7± 2.0 3.2± 0.8 0.32 14.1± 0.2 1.6± 0.0 0.08 
 Intestinal 24.5± 2.1 8.9± 1.4 0.34 49.1± 1.3 1.5± 0.0 0.12 
B7 Gastric 11.9± 1.9 3.9± 1.5 0.63 10.7± 0.3 2.0± 0.1 0.23 
 Intestinal 23.3± 3.7 7.8± 2.4 0.60 41.5± 2.3 1.6± 0.0 0.27 
C1 Gastric 7.3± 0.7 7.0± 1.7 0.27 9.0± 0.5 1.9± 0.1 0.19 
 Intestinal 20.7± 2.7 11.9± 4.7 1.35 26.2± 0.6 2.4± 0.1 0.28 
C2 Gastric 2.2± 0.3 2.3± 0.7 0.08 1.6± 0.1 1.8 ± 0.1 0.06 
 Intestinal 14.9± 4.2 0.3± 0.1 0.44 3.4± 0.1 1.5 ± 0.1 0.26 
C3 Gastric 2.6± 0.2 3.0± 0.8 0.12 2.0± 0.1 2.1± 0.1 0.07 
 Intestinal 6.3± 0.5 1.8± 0.4 0.29 3.6± 0.1 2.3 ± 0.1 0.18 
C4 Gastric 7.4± 1.2 2.8± 0.8 0.19 7.1± 0.6 1.5± 0.1 0.19 
 Intestinal 19.1± 0.8 20.2± 2.8 0.57 26.0± 2.0 2.5± 0.2 0.88 
C5 Gastric 13.3± 1.2 2.0± 0.4 0.30 9.3± 0.1 1.7± 0.0 0.07 
 Intestinal 23.6± 0.9 4.6± 0.4 0.25 26.6± 1.3 1.7± 0.1 0.46 
C6 Gastric 6.3± 0.6 1.8± 0.2 0.04 5.6± 0.2 1.3± 0.1 0.05 
 Intestinal 20.6± 3.4 2.3± 0.9 1.11 14.4± 0.2 2.0± 0.1 0.31 
C7 Gastric 
Intestinal 
3.2± 0.5 
15.7± 0.6 
4.7± 1.4 
4.3± 0.4 
0.09 
0.30 
3.9± 0.1 
13.7± 0.7 
1.6± 0.1 
2.1± 0.2 
0.03 
0.63 
Qmax: maximum adsorption capacity; KL: Langmuir affinity constant; KF: Freundlich capacity constant; n: adsorption 766 
intensity; RMSE: root-mean-square error; NC (not converge). 767 
 768 
  769 
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 Table 6. OTA adsorption (0.05-1 mg/L) Langmuir and Freundlich parameters of 14 adsorbents 770 
tested at 0.02% (w/v), in gastric (pH 1.3) and intestinal (pH 6.8) simulated juice. B: pre-selected 771 
bentonites; C: commercial adsorbents. 772 
                                             Langmuir                                 Freundlich 773 
Adsorbent Juice 𝑸𝒎𝒂𝒙 
(mg/g) 
𝑲𝑳 
(L/mg) 
RMSE 𝑲𝑭 
(mg/L) 
N RMSE 
B1 Gastric NC NC NC 0.06 0.8± 0.0 0.0009 
 Intestinal NC NC NC 0.00 0.9± 0.1 0.0002 
B2 Gastric NC NC NC 0.01 2.2± 0.6 0.0011 
 Intestinal NC NC NC NC NC NC 
B3 Gastric NC NC NC 0.12 3.1± 0.4 0.007 
 Intestinal NC NC NC NC NC NC 
B4 Gastric 1.6± 0.2 1.6± 0.4 0.0 1.08 1.6± 0.1 0.0309 
 Intestinal NC NC NC 0.24 0.8± 0.2 0.0196 
B5 Gastric NC NC NC 0.04 1.0± 0.0 0.0010 
 Intestinal NC NC NC 0.05 1.0± 0.1 0.0004 
B6 Gastric 0.5± 0.4 0.3± 0.2 0.00 0.12 1.1± 0.1 0.0015 
 Intestinal NC NC NC NC 2.4± 0.4 0.0005 
B7 Gastric NC NC NC 0.06 0.9± 0.1 0.0025 
 Intestinal NC NC NC NC 1.1± 0.3 0.0009 
C1 Gastric 0.4± 0.1 2.8± 1.7 0.0 0.32 2.1± 0.3 0.0231 
 Intestinal NC NC NC NC NC NC 
C2 Gastric 0.2± 0.1 1.4± 0.9 0.0 0.14 1.8± 0.3 0.0131 
 Intestinal NC NC NC NC NC NC 
C3 Gastric 0.6± 0.2 1.0± 0.6 0.0 0.28 1.6± 0.1 0.0170 
 Intestinal NC NC NC 0.04 6.3± 0.6 0.0016 
C4 Gastric 0.3± 0.1 3.6± 2.7 0.0 0.23 2.1± 0.4 0.0244 
 Intestinal NC NC NC 0.04 5.3± 1.9 0.0054 
C5 Gastric NC NC NC 0.05 1.1± 0.1 0.0017 
 Intestinal NC NC NC 0.01 1.4± 0.2 0.0007 
C6 Gastric NC NC NC 0.02 0.2± 0.1 0.0006 
 Intestinal NC NC NC NC 0.4± 0.2 0.0007 
C7 Gastric 
Intestinal 
NC 
NC 
NC 
NC 
NC 
NC 
0.01 
NC 
1.0± 0.3 
0.7± 0.2 
0.0011 
0.0006 
Qmax: maximum adsorption capacity; KL: Langmuir affinity constant; KF Freundlich capacity constant; n: adsorption 774 
intensity; RMSE: root-mean-square error; NC (not converge). 775 
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 Table 7. Effect of B2 and B4 adsorbent dosage on aflatoxin B1 (AFB1) and ochratoxin A (OTA) 787 
adsorption.                                                                                            788 
  Mycotoxin adsorption (%) 
Bentonite Dosage (%, w/v) AFB1 OTA 
B2 0.02 97.9a 3.2a 
 0.12 99.7b 18.7b 
 0.20 99.8b 27.7c 
B4 0.02  96.3a 15.1a 
 0.12 99.8b 55.0b 
 0.20 99.9b 75.0c 
Values are average level of three triplicates. % RSDs in all cases were <5. Means with 789 
different superscript letters are different at P<0.05. 790 
 791 
 792 
 793 
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